Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a. [electronic resource]
Producer: 19960801Description: 2403-5 p. digitalISSN:- 0959-8049
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- therapy
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Etoposide -- administration & dosage
- Female
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Lung Neoplasms -- therapy
- Male
- Middle Aged
- Recombinant Proteins
- Remission Induction
- Survival Analysis
- Thymalfasin
- Thymosin -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.